Intuitive Surgical, Inc. (ETR:IUI1)

Market Cap	158.11B
Revenue (ttm)	8.06B
Net Income (ttm)	2.29B
Shares Out	n/a
EPS (ttm)	6.32
PE Ratio	69.02
Forward PE	62.79
Dividend	n/a
Ex-Dividend Date	n/a

Volume	367
Average Volume	209
Open	434.05
Previous Close	436.85
Day's Range	432.00 - 447.15
52-Week Range	365.00 - 599.00
Beta	n/a
RSI	40.57
Earnings Date	Jul 15, 2025

About Intuitive Surgical

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1995
• Employees: 15,638
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: IUI1

Financial Performance

In 2024, Intuitive Surgical's revenue was $8.35 billion, an increase of 17.24% compared to the previous year's $7.12 billion. Earnings were $2.32 billion, an increase of 29.18%.

Financial numbers in USD